Yes, benzodiazepines are controlled substances in the United States. The Drug Enforcement Administration classifies all benzodiazepines as Schedule IV under the Controlled Substances Act, meaning they have a recognized medical use but carry a potential for abuse and dependence. This classification affects how they’re prescribed, refilled, and carried across borders.
What Schedule IV Means
The DEA uses five schedules to rank controlled substances, with Schedule I being the most restricted and Schedule V the least. Schedule IV substances are defined as drugs with a low potential for abuse relative to substances in higher schedules and a low risk of dependence. This puts benzodiazepines in the same category as sleep aids like zolpidem (Ambien) and the pain reliever tramadol.
“Low potential for abuse” is relative. Compared to Schedule II substances like oxycodone or amphetamines, benzodiazepines carry less risk. But the FDA still considers the dangers significant enough to require its strongest safety label, a Boxed Warning, on every benzodiazepine prescription. That warning specifically addresses the risks of abuse, addiction, physical dependence, and withdrawal reactions.
Which Benzodiazepines Are Controlled
Every benzodiazepine prescribed in the U.S. falls under Schedule IV. The most commonly prescribed include:
- Alprazolam (Xanax)
- Diazepam (Valium)
- Lorazepam (Ativan)
- Clonazepam (Klonopin)
- Temazepam (Restoril)
- Midazolam (Versed)
- Triazolam (Halcion)
There are no benzodiazepines that sit outside this classification. The scheduling applies to the parent chemical and its salts, isomers, and derivatives.
Why Benzodiazepines Are Controlled
The controlled status reflects real risks with these medications. Roughly 11 to 15 percent of U.S. adults take a benzodiazepine at least once in a given year, but only 1 to 2 percent take them daily for a year or longer. The concern isn’t just recreational misuse. Physical dependence can develop in as little as one to two months when someone takes a high dose of a potent, fast-acting benzodiazepine like alprazolam.
Not all benzodiazepines carry equal risk. Those that cross into the brain quickly and leave the body fast tend to be more reinforcing, which is why alprazolam and lorazepam are more commonly associated with misuse than slower-acting options like chlordiazepoxide. About 80 percent of benzodiazepine abuse involves other substances too, most often opioids.
Tolerance is another factor behind the scheduling. The body adjusts to benzodiazepines over time, particularly their sleep-inducing effects. Tolerance to the anxiety-relieving effects develops more slowly, but there’s limited evidence that benzodiazepines remain effective after four to six months of regular use. This creates pressure to increase doses, which deepens physical dependence.
What Withdrawal Looks Like
Stopping benzodiazepines abruptly after regular use can trigger withdrawal symptoms that range from uncomfortable to dangerous. The most common effects include rebound anxiety, insomnia, elevated heart rate and blood pressure, tremors, and heightened sensitivity to sounds and light. The most serious withdrawal complications are seizures and delirium, which typically occur with sudden discontinuation rather than gradual dose reduction.
The FDA specifically warns against stopping benzodiazepines without a tapering plan. Even medications designed for very short-term use (one to two doses) can cause life-threatening withdrawal if they’ve been taken longer than intended and stopped suddenly. A gradual taper, adjusted to the individual, is the standard approach. If withdrawal symptoms appear during tapering, the dose may need to be temporarily increased before resuming a slower reduction.
How Scheduling Affects Your Prescription
Because benzodiazepines are Schedule IV, federal law places specific limits on prescriptions. A benzodiazepine prescription expires six months after it’s written. Within that six-month window, you can receive a maximum of five refills. After that, you need a new prescription from your provider.
These rules are less restrictive than those for Schedule II drugs (which cannot be refilled at all and require a new prescription each time), but stricter than for non-controlled medications, which can often be refilled for a year or more. Your state may impose additional restrictions on top of the federal rules, including limits on the quantity dispensed or requirements for electronic prescribing.
Traveling With Benzodiazepines
Carrying a benzodiazepine prescription while traveling requires some planning, especially for international trips. Within the U.S., keeping the medication in its original labeled container with your name, prescriber’s name, and dosage is generally sufficient. For international travel, the rules vary significantly by country.
Many countries allow a 30-day supply of controlled medications but require you to carry a copy of your prescription or a medical certificate from your provider. Some countries restrict or ban certain controlled substances entirely. The CDC recommends checking with the embassy of your destination country, and any layover countries, before traveling. Carrying copies of all written prescriptions with both brand and generic drug names adds a layer of protection against complications at customs.
Disposing of Unused Medication
Because benzodiazepines are controlled substances, leaving unused pills in a medicine cabinet creates a safety risk. The FDA recommends using a drug take-back program as the first option. Many pharmacies and law enforcement agencies host take-back locations or provide prepaid mail-back envelopes for safe disposal.
Most benzodiazepines are not on the FDA’s flush list, which means you should not flush them down the toilet. The one exception is diazepam rectal gel, which the FDA does include on the flush list due to its high risk of accidental exposure. For all other benzodiazepine formulations, a take-back program or following specific disposal instructions from your pharmacist is the appropriate route.
Classification Outside the U.S.
Benzodiazepines are controlled in most countries, though the specific classification differs. In the United Kingdom, they fall under Class C of the Misuse of Drugs Act 1971, the lowest of three tiers. This is broadly comparable to the U.S. Schedule IV designation, reflecting a consensus across regulatory systems that benzodiazepines carry meaningful risks but remain medically useful when appropriately prescribed. If you’re moving between countries or managing a prescription internationally, be aware that the exact rules around quantity limits, required documentation, and permissible formulations can differ substantially.